Gly3-Val-Cit-PAB-MMAE CAS:2684216-48-4 is a cutting-edge drug-linker conjugate designed for the development of antibody-drug conjugates (ADCs) in cancer therapy.
Payloads and Linker modified Payloads
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。